Suivre
Jeffrey Weitz
Jeffrey Weitz
Professor of Medicine and Biochemistry and Biomedical Sciences, McMaster University
Adresse e-mail validée de mcmaster.ca
Titre
Citée par
Citée par
Année
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
61812013
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
CT Ruff, RP Giugliano, E Braunwald, EB Hoffman, N Deenadayalu, ...
The Lancet 383 (9921), 955-962, 2014
59842014
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American college of cardiology 75 (23), 2950-2973, 2020
35202020
Oral apixaban for the treatment of acute venous thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, ...
New England Journal of Medicine 369 (9), 799-808, 2013
28982013
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer
PS Wells, DR Anderson, M Rodger, JS Ginsberg, C Kearon, M Gent, ...
Thrombosis and haemostasis 83 (03), 416-420, 2000
24522000
Low-molecular-weight heparins
JI Weitz
New England Journal of Medicine 337 (10), 688-698, 1997
21811997
Idarucizumab for dabigatran reversal
CV Pollack Jr, PA Reilly, J Eikelboom, S Glund, P Verhamme, ...
New England Journal of Medicine 373 (6), 511-520, 2015
20872015
Thrombosis: a major contributor to global disease burden
GE Raskob, P Angchaisuksiri, AN Blanco, H Buller, A Gallus, BJ Hunt, ...
Arteriosclerosis, thrombosis, and vascular biology 34 (11), 2363-2371, 2014
18072014
Edoxaban for the treatment of cancer-associated venous thromboembolism
GE Raskob, N Van Es, P Verhamme, M Carrier, M Di Nisio, D Garcia, ...
New England Journal of Medicine 378 (7), 615-624, 2018
17762018
Hematology E-Book: Basic Principles and Practice
R Hoffman, EJ Benz, LE Silberstein, H Heslop, J Weitz, ME Salama
Elsevier Health Sciences, 2022
17552022
Apixaban for extended treatment of venous thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, A Porcari, ...
New England Journal of Medicine 368 (8), 699-708, 2013
17482013
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
JW Eikelboom, J Hirsh, JI Weitz, M Johnston, Q Yi, S Yusuf
Circulation 105 (14), 1650-1655, 2002
16702002
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
M Levine, M Gent, J Hirsh, J Leclerc, D Anderson, J Weitz, J Ginsberg, ...
New England Journal of Medicine 334 (11), 677-681, 1996
16511996
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
C Kearon, M Gent, J Hirsh, J Weitz, MJ Kovacs, DR Anderson, AG Turpie, ...
New England Journal of Medicine 340 (12), 901-907, 1999
15111999
Use of a clinical model for safe management of patients with suspected pulmonary embolism
PS Wells, JS Ginsberg, DR Anderson, C Kearon, M Gent, AG Turpie, ...
Annals of internal medicine 129 (12), 997-1005, 1998
14921998
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
JI Weitz, M Hudoba, D Massel, J Maraganore, J Hirsh
The Journal of clinical investigation 86 (2), 385-391, 1990
14721990
Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review
JI Weitz, J Byrne, GP Clagett, ME Farkouh, JM Porter, DL Sackett, ...
Circulation 94 (11), 3026-3049, 1996
13331996
Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines
DA Garcia, TP Baglin, JI Weitz, MM Samama
Chest 141 (2), e24S-e43S, 2012
13052012
Idarucizumab for dabigatran reversal—full cohort analysis
CV Pollack Jr, PA Reilly, J Van Ryn, JW Eikelboom, S Glund, ...
New England Journal of Medicine 377 (5), 431-441, 2017
12872017
Accuracy of clinical assessment of deep-vein thrombosis
PS Wells, J Hirsh, DR Anderson, AWA Lensing, G Foster, C Kearon, ...
The Lancet 345 (8961), 1326-1330, 1995
11381995
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20